Hjem › Sigdcelleanemi › District of Columbia › Washington
Kliniske studier for Sigdcelleanemi i Washington, DC
20 studier for Sigdcelleanemi søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Blood Sampling for Research Related to Sickle Cell Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
- Childrens National Hospital, Washington D.C.
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
RekruttererTidlig fase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekruttererFase 3
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
RekruttererFase 1
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7 mi unna
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
RekruttererFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RekruttererObservasjonsstudie
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RekruttererFase 2
- Center for Cancer and Blood Disorders, Bethesda · 7 mi unna
Cooperative Assessment of Late Effects for SCD Curative Therapies
RekruttererObservasjonsstudie
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekruttererObservasjonsstudie
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
RekruttererFase 2
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
RekruttererFase 2
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
RekruttererFase 2
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
Rekrutterer
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Rekrutterer
- Children's National Hospital, Washington D.C.
Sigdcelleanemi-studier i andre byer
- Atlanta, GA22 studier
- Chicago, IL18 studier
- Memphis, TN18 studier
- Philadelphia, PA15 studier
- Birmingham, AL14 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Boston, MA10 studier
- Durham, NC10 studier
- Houston, TX10 studier
- Cincinnati, OH10 studier
- Greenville, NC9 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.